Market Overview

Kindred Healthcare Has Near-Term Headwinds According To Avondale; Price Target Cut

Share:
Kindred Healthcare Has Near-Term Headwinds According To Avondale; Price Target Cut
Related KND
Wall Street's M&A Chatter From April 20: Kindred, Virtu-KCG, Westar-Great Plains Energy
15 Biggest Mid-Day Gainers For Tuesday

Avondale Partners has cut the price target of Kindred Healthcare, Inc. (NYSE: KND) to $14 from $17 citing near-term headwinds in the hospital division (HD).

"We continue to believe that 2H headwinds from criteria in the HD as well as skepticism surrounding cash flow generation may continue to pressure KND's ability to warrant an expanded multiple," analyst Paula Torch wrote in a note.

The analyst noted that the stock is down about 23 percent since the first-quarter earnings report at the beginning of May, partly due to cash flow expectations and reconciling adjustments as well as risks surrounding the second half performance in HD due to criteria.

"Earnings in 2016 are geared to 1H and embarking on a softer 2H could also be weighing on shares," Torch highlighted.

Related Link: Analysts Give Healthcare Sector A Clean Bill Of Health

However, the analyst raised her full-year EPS view to $0.90 from $0.88 due to the first quarter beat and solid second-quarter guidance. The analyst also raised her 2017 EPS estimate by $0.01 to $0.94.

Torch, who maintained her Market Perform rating on the stock, said the company's range of care and diverse level of post-acute services should serve the company in the long term.

Shares of Kindred Healthcare closed Thursday's regular trading session 1.06 percent lower at $11.17, but were up 3.45 percent to $11.55 within the first hour of trading Friday.

Latest Ratings for KND

DateFirmActionFromTo
Nov 2016RBC CapitalDowngradesOutperformSector Perform
Nov 2016Stifel NicolausDowngradesHoldSell
Aug 2016UBSMaintainsNeutral

View More Analyst Ratings for KND
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Health Care Price Target Reiteration Analyst Ratings Trading Ideas General

 

Related Articles (KND)

View Comments and Join the Discussion!